CPAY: Q3 beat and raised FY26 guidance as organic growth held at 11%

What happened

CPAY reported that Q3 revenue and adjusted earnings per share (EPS) exceeded guidance, organic growth was 11%, and adjusted EBITDA, a measure of operating earnings, increased 17%. It raised the FY26 guidance midpoint to $5.35B in revenue and $28.00 adjusted EPS, and said proceeds from maintenance sales are slated to reduce borrowed money.

Confirmed

Global impact / market context

Beating guidance while holding organic growth at 11% suggests the business is expanding without relying solely on acquisitions. Higher FY26 targets could support expectations for future revenue and earnings, while using maintenance-sale proceeds to reduce borrowed money could lower financing costs over time.

Analyst inference

The update combines stronger reported results with higher forward targets, giving investors new figures to compare against earlier expectations. The planned debt reduction is a separate capital-allocation signal; its effect depends on the proceeds received and how much borrowed money is repaid.

Analyst inference

What to watch

1. Check the full FY26 outlook for the time period covered and assumptions behind the $5.35B revenue and $28.00 adjusted EPS guidance midpoint. Analyst inference
2. Track completion and proceeds from maintenance sales, then whether the company uses that cash to repay borrowed money as stated. Confirmed
3. Compare future organic growth and adjusted earnings with the raised outlook; slowing growth or a shortfall could weaken confidence in the guidance. Analyst inference

Evidence

• Original source link unavailable